Allogene Therapeutics Statistics
Total Valuation
ALLO has a market cap or net worth of $269.68 million. The enterprise value is $102.62 million.
Important Dates
The last earnings date was Thursday, November 6, 2025, after market close.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ALLO has 224.73 million shares outstanding. The number of shares has increased by 17.65% in one year.
| Current Share Class | 224.73M |
| Shares Outstanding | 224.73M |
| Shares Change (YoY) | +17.65% |
| Shares Change (QoQ) | +1.42% |
| Owned by Insiders (%) | 6.66% |
| Owned by Institutions (%) | 66.74% |
| Float | 167.85M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.85 |
| P/TBV Ratio | 0.86 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.19, with a Debt / Equity ratio of 0.27.
| Current Ratio | 8.19 |
| Quick Ratio | 7.99 |
| Debt / Equity | 0.27 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -266.93 |
Financial Efficiency
Return on equity (ROE) is -54.43% and return on invested capital (ROIC) is -29.40%.
| Return on Equity (ROE) | -54.43% |
| Return on Assets (ROA) | -27.34% |
| Return on Invested Capital (ROIC) | -29.40% |
| Return on Capital Employed (ROCE) | -55.16% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$925,830 |
| Employee Count | 229 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ALLO has paid $443,000 in taxes.
| Income Tax | 443,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -57.75% in the last 52 weeks. The beta is 0.49, so ALLO's price volatility has been lower than the market average.
| Beta (5Y) | 0.49 |
| 52-Week Price Change | -57.75% |
| 50-Day Moving Average | 1.22 |
| 200-Day Moving Average | 1.38 |
| Relative Strength Index (RSI) | 49.20 |
| Average Volume (20 Days) | 2,369,925 |
Short Selling Information
The latest short interest is 19.09 million, so 8.50% of the outstanding shares have been sold short.
| Short Interest | 19.09M |
| Short Previous Month | 19.49M |
| Short % of Shares Out | 8.50% |
| Short % of Float | 11.38% |
| Short Ratio (days to cover) | 6.74 |
Income Statement
| Revenue | n/a |
| Gross Profit | -166.49M |
| Operating Income | -225.02M |
| Pretax Income | -211.57M |
| Net Income | -212.02M |
| EBITDA | -212.48M |
| EBIT | -225.02M |
| Earnings Per Share (EPS) | -$0.98 |
Full Income StatementBalance Sheet
The company has $252.19 million in cash and $85.14 million in debt, giving a net cash position of $167.05 million or $0.74 per share.
| Cash & Cash Equivalents | 252.19M |
| Total Debt | 85.14M |
| Net Cash | 167.05M |
| Net Cash Per Share | $0.74 |
| Equity (Book Value) | 315.33M |
| Book Value Per Share | 1.41 |
| Working Capital | 228.89M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$158.35 million and capital expenditures -$643,000, giving a free cash flow of -$158.99 million.
| Operating Cash Flow | -158.35M |
| Capital Expenditures | -643,000 |
| Free Cash Flow | -158.99M |
| FCF Per Share | -$0.71 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ALLO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -17.65% |
| Shareholder Yield | -17.65% |
| Earnings Yield | -78.62% |
| FCF Yield | -58.96% |
Analyst Forecast
The average price target for ALLO is $8.67, which is 622.50% higher than the current price. The consensus rating is "Buy".
| Price Target | $8.67 |
| Price Target Difference | 622.50% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 605.93% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ALLO has an Altman Z-Score of -5.57 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.57 |
| Piotroski F-Score | 1 |
